Reduced bone density at completion of chemotherapy for a malignancy - Wikidata - wikimedia - TriplyDB

Reduced bone density at completion of chemotherapy for a malignancy

Reduced bone density at completion of chemotherapy for a malignancy

http://www.wikidata.org/entity/Q35262328

about

Bortezomib is cytotoxic to the human growth plate and permanently impairs bone growth in young mice Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients.The impact of corticosteroids on growth and bone health.Avoiding the under-diagnosis of low bone mineral density in Egyptian children with chronic medical conditions affecting bone health.Vitamin D and Bone Minerals Status in the Long-term Survivors of Childhood Acute Lymphoblastic Leukemia.Bone mineral density decrements and children diagnosed with cancer.Bone mineral density and bone metabolism in children treated for bone sarcomas.Low bone mass in children with malignant lymphoma.

P2860

Q28485441-0F0343F3-3AAD-4C0C-993B-3E2933C2864E Q33781670-5D891D01-2B4D-4696-81F1-E61BDD42F9FD Q35273301-2C369108-2C29-4DB7-8C3F-3595F32C1F32 Q35674283-2BE468B8-9E13-4E5B-977E-C76F45954A94 Q36103622-7CCC1BAE-1991-431E-9B03-195F61DF9BB7 Q36282725-DF0BAC8A-4B1A-4D2F-8DE4-07FD50719915 Q40330536-69964F71-0DDE-4DA9-9C2C-F8644CEC57E4 Q46278585-A69878FD-AE5D-4913-9F88-DA50AE46666B

P2860

Reduced bone density at completion of chemotherapy for a malignancy

http://www.wikidata.org/entity/Q35262328

description

1999 nî lūn-bûn

@nan

1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Reduced bone density at completion of chemotherapy for a malignancy

@ast

Reduced bone density at completion of chemotherapy for a malignancy

@en

type

label

Reduced bone density at completion of chemotherapy for a malignancy

@ast

Reduced bone density at completion of chemotherapy for a malignancy

@en

prefLabel

Reduced bone density at completion of chemotherapy for a malignancy

@ast

Reduced bone density at completion of chemotherapy for a malignancy

@en

P1433

Q35262328-F621A911-CF14-4631-99FA-9787A92042A1

P1476

Q35262328-AD02151C-F1BE-4823-AB31-CD52CB844AB8

P2093

Q35262328-07F5A855-09A6-4D24-A81E-64F3B9BA1BDF

Q35262328-7B5D3230-0288-4A3B-87D9-DB68A4F93F1C

Q35262328-955C5C71-E4A5-4BC3-9790-81EEBBD2339D

Q35262328-9653CDB7-7668-4DBC-A5C3-7E89553B4BAC

Q35262328-B15C5792-43BE-4D61-8BBB-787A730EB64B

Q35262328-CAE2E7A8-0BA3-460E-82CC-0C3B8C49809E

P2860

Q35262328-0EAD2593-019A-4116-8DF4-CCD1C7404CDE

Q35262328-277C64FA-269E-4EC6-A6FF-16BD98257D6B

Q35262328-27E8B8F8-1055-474D-B63D-0F4B8B51D8AC

Q35262328-35093DFB-9701-4B71-9293-5C4FF3CE3C32

Q35262328-4B7D9FC4-FED8-4403-AB02-161F91104E46

Q35262328-60740850-4557-46FC-9189-81EFE70367F0

Q35262328-6F99EE08-EA96-433F-BA55-3C160A6C55BF

Q35262328-7FC20710-68DC-4BFB-96FD-E66148CAB204

Q35262328-865B6481-1BFA-464E-89A1-C3F4A176B363

Q35262328-87B13273-49E8-46C5-BB7F-50A144023199

P304

Q35262328-495C48D1-D8A3-4B8F-BAC6-95979F2C9738

P31

Q35262328-B7E7465A-656C-4E9C-A3A6-B03C64292C8A

P356

Q35262328-8DF6B8B8-2E43-4C6F-BF96-7D87EAE94A57

P407

Q35262328-BBF436D8-862C-4A36-87EE-4E0D201958C5

P433

Q35262328-DA5BF4CF-334F-4AD4-A15E-9B72736EF0E3

P478

Q35262328-D2A0448A-0262-4521-83ED-BC36E30C187A

P577

Q35262328-B033F82D-6D80-44C6-8A6E-5479C4623BAA

P5875

Q35262328-7897A881-B2F6-4A7D-A89F-C01BF3D48E09

P698

Q35262328-C66C1A40-B5FE-4047-B109-A38496DD9852

P921

Q35262328-78664276-8EFD-4D0A-95EB-9734DEB160FA

P932

Q35262328-4A6AC26B-6180-48C3-9E69-C72115D726F5

P356

P1433

Archives of Disease in Childhood

P1476

Reduced bone density at completion of chemotherapy for a malignancy

@en

P2093

Arikoski P

http://www.w3.org/2001/XMLSchema#string

Jurvelin JS

http://www.w3.org/2001/XMLSchema#string

Komulainen J

http://www.w3.org/2001/XMLSchema#string

Kröger H

http://www.w3.org/2001/XMLSchema#string

Riikonen P

http://www.w3.org/2001/XMLSchema#string

Voutilainen R

http://www.w3.org/2001/XMLSchema#string

P2860

Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry.

Endocrine consequences of treatment of malignant disease.

Development of bone mass and bone density of the spine and femoral neck--a prospective study of 65 children and adolescents.

Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.

Management of growth failure in the treatment of malignant disease.

Local and systemic factors in the pathogenesis of osteoporosis.

Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis.

The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations.

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

Bone mass acquisition during infancy, childhood and adolescence.

P304

143-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ADC.80.2.143

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12972423

http://www.w3.org/2001/XMLSchema#string

P698

10325729

http://www.w3.org/2001/XMLSchema#string

P921

P932

1717834

http://www.w3.org/2001/XMLSchema#string